Progyny CEO Peter Anevski sells $6.18 million in company stock

Progyny's CEO Peter Anevski exercised stock options and sold a total of approximately $6.18 million worth of company shares in early November 2026, according to a SEC filing. In multiple transactions, Anevski acquired 129,604 shares through the exercise of options at $0.91 per share, which totaled around $117,939. These fully vested options were then sold, with the first sale occurring on November 5, when Anevski sold 3,400 shares at an average price of $35.2276.

The following day, he sold an additional 8,539 shares under a Rule 10b5-1 trading plan at an average price of $35.0906. Further sales took place on November 9, with 126,204 shares sold at an average price of $35.7257, and another 35,104 shares under the same Rule 10b5-1 plan at the same price point. In total, the direct sales of shares generated approximately $4,628,500, while the sales under the 10b5-1 plan added about $1,553,753, amounting to a combined total of roughly $6.18 million.

Following these reported transactions, Anevski personally holds 762,468 shares of Progyny common stock. He remains the company's Chief Executive Officer and a Director. Progyny's stock is currently trading near its 52-week high of $36, having delivered a 52% return over the past year. The company is perceived as undervalued with a PEG ratio of 0.39, indicating strong value relative to its growth prospects. Industry analysts from InvestingPro believe Progyny remains a compelling investment opportunity.